Issues; Trends and Prevalence in the European Cancer Therapy Market- Non Pharmaceutical

SUMMARY

This research service examines the Issues, trends and prevalence in the European cancer therapy market in terms of the challenges faced by market participants, drivers, and restraints in the industry, the competitive structure in the major markets as well as the upcoming technologies.

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

• Summary of Major Findings
  • 1. Executive Summary

2. RESEARCH SCOPE AND METHODOLOGY

• Scope and Methodology
  • 1. Scope and Methodology

3. INTRODUCTION

• Introduction
  • 1. Research Study Overview
  • 2. Cancer

4. TYPES OF CANCER

• Introduction
  • 1. Introduction to Types of Cancers
• Breast Cancer
  • 1. Introduction
  • 2. Staging
  • 3. Treatment Modality
  • 4. Issues and Trends
  • 5. Prevalence
• Lung Cancer
  • 1. Introduction
  • 2. Staging
  • 3. Treatment Modality
  • 4. Issues and Trends
  • 5. Prevalence
• Colon Cancer
  • 1. Introduction
  • 2. Staging
  • 3. Treatment Modality
  • 4. Issues and Trends
  • 5. Prevalence
• Prostate Cancer
  • 1. Introduction
  • 2. Staging
  • 3. Treatment Modality
  • 4. Issues and Trends
  • 5. Prevalence
• Leukemia
  • 1. Introduction
  • 2. Staging
  • 3. Treatment Modality
  • 4. Issues and Trends
  • 5. Prevalence
• Lymphoma
  • 1. Introduction
  • 2. Staging
  • 3. Treatment Modality
  • 4. Issues and Trends
  • 5. Prevalence
• Uterine Cancer
  • 1. Introduction
  • 2. Staging
  • 3. Treatment Modality
  • 4. Issues and Trends
  • 5. Prevalence

5. MARKET OUTLOOK

• Introduction
  • 1. Radiotherapy Devices
• Industry Challenges
  • 1. Challenges in the European Market
• Drivers and Restraints
  • 1. Drivers
  • 2. Restraints
• Key Market Participants and Products Available
  • 1. Key Market Participants
  • 2. Key Products
• Country Profile
  • 1. Germany
  • 2. France
  • 3. Italy
  • 4. Spain
  • 5. United Kingdom
  • 6. Benelux
  • 7. Scandinavia
• Radiotherapy Resources
  • 1. Radiotherapy Resources in Europe
• Treatment Distribution
  • 1. Treatment Distribution in Europe

6. THINKING OUTSIDE THE BOX

• Competitive Structure and Opportunities
  • 1. Competitive Structure
  • 2. Opportunities
• Future Outlook
  • 1. A Future Outlook for the European Industry
• Conclusion
  • 1. Radiotherapy Devices- Conclusion

7. DECISION SUPPORT DATABASE

• Database
  • 1. Number of Hospitals- Western Europe
  • 2. Private Healthcare Expenditure
  • 3. Government Healthcare Expenditure
  • 4. Population Aged 65 and above
  • 5. Per Capita Healthcare Expenditure